| Financial Year |
March 31 2023 |
| Monetary Funds |
422,896,156.76 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
712,211.94 |
| Accounts Receivable |
1,058,948,563.37 |
| Advances to Suppliers |
14,388,352.41 |
| Other Receivables |
13,222,057.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
434,248,944.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,507,979.20 |
| Total Current Assets |
2,040,893,693.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
327,643,961.17 |
| Under-construction Projects |
51,640,668.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,356,140.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,996,114.22 |
| Deferred Income Tax Assets |
24,983,844.51 |
| Other Non-Current Assets |
60,735,427.76 |
| Sub-Total of Non-Current Assets |
560,546,693.25 |
| Total Assets |
2,601,440,386.46 |
| Short-Term Loans |
259,235,416.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
261,630,147.24 |
| Accounts Payable |
516,026,508.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,953,757.25 |
| Taxes Payable |
11,755,819.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,647,002.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,694,350.29 |
| Other Current Liabilities |
1,911,566.81 |
| Sub-Total of Current Liabilities |
1,138,558,928.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,592,369.49 |
| Total Liabilities |
1,157,151,298.46 |
| Paid-In Capital(Or Share Stock) |
125,070,700.00 |
| Capital Surplus |
814,865,750.51 |
| Surplus Reserve |
43,635,080.36 |
| LESS:Treasury Stock |
106,371,141.66 |
| Undistributed Profits |
558,588,376.64 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,444,289,088.00 |
| Owner's Equity（Stockholder's Equity） |
1,444,289,088.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,601,440,386.46 |
